Overseas Consensus LLC

Overseas Consensus LLC specializes in synthetic polymer semi-permeable film dressings with adhesive properties. These devices are primarily designed for wound care, such as the Medrull Ultra Pore Adhesive Wound Dressing, which helps manage minor to moderate wounds. The focus is on products that provide a protective barrier while allowing moisture vapor to escape, aiding in the wound healing process.

Overseas Consensus LLC is headquartered in the United States. The company’s location ensures compliance with U.S. regulatory standards, including those governing medical device manufacturing and distribution.

Overseas Consensus LLC’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry is used to track and identify medical devices in the U.S., ensuring traceability and compliance with regulatory requirements.

Overseas Consensus LLC’s devices fall under FDA’s Class I classification. This classification applies to low-risk medical devices, such as certain wound dressings, where the risk of illness or injury is minimal. Class I devices typically require general controls to ensure safety and effectiveness, such as good manufacturing practices and labeling requirements.